Abiopharma

Prime Medicine Announces New Zealand Clearance of Clinical Trial Application for PM577a in H1069Q-mutated Wilson Disease

Letter to Shareholders from Conn Davis, Chief Executive Officer: First 100 Days

BioCardia Letter to Stockholders on 2026 Priorities and Strategic Opportunities

RoboStrategy, Inc. Raises Approximately $28.9 Million Through Private Share Issuances

Hollister Teams Up with Target for Its First-Ever Home & Dorm Collaboration

Pinnacle Financial Partners Announces New Corporate Headquarters at Ten Twenty Spring in Midtown Atlanta

Energy Fuels Receives Conditional U.S. Government Support to Accelerate Growth in Rare Earths and Critical Materials

Premier Air Charter Discusses FAA Approval, Growth Strategy, and Market Trends in Follow-Up Interview

Enphase Energy Begins Shipments of GaN-Based 548 VA IQ9S Commercial Microinverters in the United States

Trio Petroleum Corp Provides Update on Acquisition Strategy and Ongoing Operations